title: Ceftriaxone and cefotaxime are equally effective in the treatment of neutropenic fever.
authors.affiliation: Klinik für Innere Medizin, Universitätsklinik Köln, Deutschland. Oliver.Cornely@uni-koeln.de
authors.forename: O A
authors.initials: OA
authors.lastname: Cornely
authors.forename: B
authors.initials: B
authors.lastname: Salzberger
authors.forename: U
authors.initials: U
authors.lastname: Bethe
authors.forename: H
authors.initials: H
authors.lastname: Seifert
authors.forename: G
authors.initials: G
authors.lastname: Fätkenheuer
authors.forename: V
authors.initials: V
authors.lastname: Diehl
authors.forename: M
authors.initials: M
authors.lastname: Schrappe
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology / Q000517:prevention & control; D002439:Cefotaxime / Q000008:administration & dosage*; D002443:Ceftriaxone / Q000008:administration & dosage*; D002511:Cephalosporins / Q000008:administration & dosage*; D005334:Fever / Q000188:drug therapy* / Q000209:etiology; D019337:Hematologic Neoplasms / Q000188:drug therapy; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D009503:Neutropenia / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D002511:Cephalosporins; D002443:Ceftriaxone; D002439:Cefotaxime